SCHEMBL7721949

SCHEMBL7721949

CC(C)(C)OC(=O)N1CC(NC(=O)[C@@H](O)CN(C=O)OC(C)(C)C)C[C@H]1C(=O)Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.38
NPC1 O15118 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HTRA1 Q92743 1/20 0.37
GHSR Q92847 1/20 0.37
MCL1 Q07820 4/20 0.36
CFTR P13569 2/20 0.36
PABPC1 P11940 1/20 0.36
EPHX2 P34913 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7721946 0.84 HDAC8 (0.41) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7722275 0.83 HDAC8 (0.42) HDAC8NPC1MEN1KMT2AGHSR
SCHEMBL7731475 0.79 HDAC8 (0.44) HDAC8NPC1MEN1KMT2AGHSR
SCHEMBL7728024 0.75 MEN1 (0.62) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7728781 0.75 MEN1 (0.62) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7728020 0.75 MEN1 (0.62) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7727701 0.74 NPC1 (0.46) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7727705 0.74 NPC1 (0.46) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7728565 0.74 MEN1 (0.51) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7728568 0.74 MEN1 (0.51) HDAC8NPC1MEN1KMT2AHTRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed